Clinical Trials in Michigan

Showing 7821-7840 of 12,290 trials

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

NCT01490866

This is a non-randomized, open-label, Phase II trial investigating axitinib as a single-agent maintenance therapy following standard first-line FOLFOX/bevacizumab therapy for patients with mCRC.

Colorectal Cancer

SCRI Development Innovations, LLC70 participantsStarted Jan 2012

Jonesboro, Arkansas, United States • Fort Myers, Florida, United States • Pensacola, Florida, United States +9 more locations

COMPLETEDPhase 283 miles

A Study in Participants With Moderate to Severe Psoriasis

NCT01107457

The primary purpose for this study is to help answer the following research questions * The safety of ixekizumab (LY2439821) and any side effects that might be associated with it. * Whether ixekizumab can help participants with Psoriasis. * How much ixekizumab should be given to participants.

Psoriasis

Eli Lilly and Company142 participantsStarted Apr 2010

Bakersfield, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +31 more locations

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

A Study in Participants With Moderate to Severe Psoriasis

Find Trials by Condition in Michigan

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

A Study in Second Line Metastatic Colorectal Cancer

Firmagon (Degarelix) Intermittent Therapy

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Study of Ramucirumab in Ovarian Cancer

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

A Study in Non-Small Cell Lung Cancer

A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

MRI to Detect Breast Tumors in Women

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus